Lineage Logistics Commits $5 Million and Launches Its “Share A Meal” Campaign to Help Provide 100 Million Meals in Response to COVID-19
23.3.2020 22:27:00 EET | Business Wire | Press release
Lineage Logistics Holdings, LLC (“Lineage” or the “Company”), the world’s largest and most innovative provider of temperature-controlled logistics, today announced its commitment to a $5 million donation and the launch of its Share A Meal campaign to help provide 100 million meals* to people in need in response to COVID-19.
“The COVID-19 virus presents extraordinary challenges for moving, storing, and distributing food on a large scale,” said Greg Lehmkuhl, Lineage’s President & CEO. “At Lineage, we’ve built a business dedicated to shepherding food all over the world, which puts us in a unique position to help overcome these challenges. We want to do our part by sharing what we have to offer – including temperature-controlled warehouse space, supply chain logistics expertise and financial resources.”
In honor of this response and to kick off the campaign, Lineage is donating $1 million to the Feeding America® COVID-19 Response Fund and will donate up to $500,000 more to match contributions made to the fundraiser run by Stephen and Ayesha Curry's Eat. Learn. Play. Foundation, in which all funds are directed to Feeding America®, the nation’s largest domestic hunger-relief organization.
“We're working in a myriad of ways to ensure that every person in need, particularly the residents of Oakland, California, has access to the food they need during this COVID-19 crisis,” said Chris Helfrich, CEO of the Eat. Learn. Play. Foundation. “We're proud to be doing this work alongside Lineage Logistics – they’ve quickly established themselves as an invaluable partner in these critical times.”
“We are very proud to join forces and launch our Share A Meal campaign with Stephen and Ayesha Curry’s Eat. Learn. Play. Foundation to work with Feeding America and provide much-needed meals from coast to coast,” said Kevin Marchetti, Co-Executive Chairman of Lineage Logistics Holdings, LLC. “We hope to connect with inspirational changemakers like the Curry’s in communities across the United States and around the world in pursuit of our goal of helping to provide 100 million meals to people in need.”
In addition to these initial commitments, Lineage is looking to work closely with a number of other strategic partners to make financial and logistical contributions in communities worldwide and reach Share A Meal ’s ambitious goal.
Lineage will engage its expansive network of customers, which includes some of the world’s largest food producers and manufacturers, to join Lineage in its commitment, and the Company will challenge its investors, vendors and other likeminded leaders and businesses to donate as well as we work together to ensure people around the world have access to the feed they need. Additionally, recognizing that COVID-19 is a worldwide crisis, Lineage has engaged with the Global FoodBanking Network, to provide funds, donate food and volunteer the Company’s storage resources and distribution expertise on a global scale.
“We have the opportunity to rise to the occasion in a critical time of need and actively live out Lineage’s purpose statement of helping to feed the world,” Lehmkuhl said. “It’s a time to ask ourselves what we stand for, and how far we are willing to go in service of others. We are 14,000 strong in communities near and far. As citizens of the world, we are in this together, and we know Lineage can – and must – do more.”
*Lineage’s goal to help provide 100 million meals will include financial and in-kind donations facilitated by Lineage and its partners to Feeding America and other hunger-relief organizations. To support Lineage’s Share a Meal campaign and make a donation to Feeding America’s COVID-19 Response Fund, please visit: www.feedingamerica.org/lineage-covid
About Lineage Logistics
Lineage is the world’s largest and most innovative provider of temperature-controlled logistics solutions. Lineage’s expertise in end-to-end logistical solutions, its unrivaled facility network, and its use of technology combine to promote food safety, increase distribution efficiency, advance sustainability, lessen environmental impact, and minimize supply chain waste. As a result, Lineage helps customers ranging from Fortune 500 companies to small family-owned businesses increase the efficiency and protect the integrity of their temperature-controlled supply chain. In recognition of the company’s leading innovations, Lineage was recognized as the No 1. Data Science company on Fast Company’s Annual list of The World’s Most Innovative Companies in 2019, in addition to ranking 23rd overall in an evaluation of thousands of companies worldwide. For more information, visit: www.lineagelogistics.com.
About Feeding America®
Feeding America® is the largest hunger-relief organization in the United States. Through a network of 200 food banks and 60,000 food pantries and meal programs, we provide meals to more than 40 million people each year. Feeding America also supports programs that prevent food waste and improve food security among the people we serve; educates the public about the problem of hunger; and advocates for legislation that protects people from going hungry. Individuals, charities, businesses and government all have a role in ending hunger. Donate. Volunteer. Advocate. Educate. Together we can solve hunger. Visit www.feedingamerica.org, find us on Facebook or follow us on Twitter.
About The Global FoodBanking Network
The Global FoodBanking Network (GFN) is an international non-profit organization that nourishes the world’s hungry through uniting and advancing food banks in more than 30 countries. GFN focuses on combating hunger and preventing food waste by providing expertise, directing resources, sharing knowledge and developing connections that increase efficiency, ensure food safety and reach more people facing hunger. Last year, 943 GFN member food banks rescued over 500 million kilograms of food and grocery product and redirected it to feed 9.6 million people through a network of more than 55,000 social service and community-based organizations. For more information please visit www.foodbanking.org.
About Eat. Learn. Play.
Founded by three-time NBA champion and two-time MVP Stephen Curry and entrepreneur, host and The New York Times bestselling author Ayesha Curry, Eat. Learn. Play. Foundation seeks to unlock the human potential of every child. Focused on youth in underserved communities, the foundation's programs are anchored around three core values vital to a successful childhood: nutrition, education and physical activity. As emerging figures in the tech and food spaces, the Curry family is committed to increasing access to quality education for K-12 students, driving innovation and creativity and paving the way for bright futures. Eat. Learn. Play.'s education focus furthermore extends through college completion with a goal to close the graduation gap between low-income and minority students and their peers. The foundation's localized programs provide nutritious food for children in low-income neighborhoods to reduce childhood hunger, the tools to learn about holistic wellness and environments for safe play. In working with community partners across the country, Eat. Learn. Play. is committed to collaboratively improving lives for today's youth generation. To support Eat. Learn. Play.’s donations to the Alameda County Community Food Bank, please visit: bit.ly/elpcovidfund
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200323005639/en/
Contact information
Megan Hendricksen
909.821.7692
mhendricksen@lineagelogistics.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
